Market Tracker

10/24 6:05pm ET

Celgene Corp (NASDAQ:CELG)

103.24
Data as of Oct 24
 +2.84 / +2.83%
Today’s Change
66.85
Today|||52-Week Range
103.31
+22.20%
Year-to-Date

Today’s Trading

Previous close100.40
Today’s open99.55
Day’s range99.21 - 103.31
Volume9,131,573
Average volume (3 months)4,693,537
Market cap$82.5B
Dividend yield--
Data as of 3:59pm ET, 10/24/2014

Growth & Valuation

Earnings growth (last year)+2.12%
Earnings growth (this year)+23.77%
Earnings growth (next 5 years)+26.00%
Revenue growth (last year)+19.49%
P/E ratio59.7
Price/Sales10.78
Price/Book15.13

Competitors

 Today’s
change
Today’s
% change
AZNAstraZeneca PLC+0.77+1.11%
BMYBristol-Myers Squibb...+1.13+2.15%
LLYEli Lilly and Co+1.70+2.64%
NVONovo Nordisk A/S+0.05+0.11%
Data as of 4:03pm ET, 10/24/2014

Financials

Last reporting dateOctober 23, 2014
EPS forecast (this quarter)$0.97
Annual revenue (last year)$6.5B
Annual profit (last year)$1.4B
Net profit margin22.36%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Robert J. Hugin
President &
Chief Operating Officer
Mark J. Alles
Corporate headquarters
Summit, New Jersey

Forecasts